Silver Book Fact

Drug-resistant infections increase length & cost of hospital stays

Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.

Mauldin, Patrick D., Cassandra D. Salgado, Ida Solhoj Hansen, Darshana T. Durup, and John A. Bosso. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria. Antimicrob Agents Chemother. 2009; 54(1): 109-15. http://aac.asm.org/content/54/1/109.full

Reference

Title
Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria
Publication
Antimicrob Agents Chemother
Publication Date
2009
Authors
Mauldin, Patrick D., Cassandra D. Salgado, Ida Solhoj Hansen, Darshana T. Durup, and John A. Bosso
Volume & Issue
Volume 54, Issue 1
Pages
109-15
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Comorbidities and hospitalization higher with HAIs
    Patients with HAIs have more comorbidities (2.8 vs. 1.9) and in-hospital mortality (9% vs. 1.5%), compared to all other hospitalized patients.  
  • Hospital stays longer when HAIs involved
    The average length of hospital stays are 19 days longer with healthcare-associated infections than without (24.4 days versus 5.2 days).  
  • Close to 1/2 of HAIs in patients 65+
    Around 45% of all hospital-acquired HAIs in 2007 were in patients age 65 and older.  
  • Dramatic increase of antibiotic resistance between 1981 and 2001
    Increase in antibiotic resistance over 20 year period  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.